Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Download PDF Copy

Jun 25 2015

NewsGuard 100/100 Score

Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market® ("NASDAQ") on June 29, 2015 under the symbol CXRX.

The Company's common shares will continue to trade on the Toronto Stock Exchange.

"Our NASDAQ listing will provide increased exposure for Concordia as we continue to build our foundation as an emerging leader in the acquisition of legacy pharmaceutical products and orphan drugs," said Mark Thompson, Chief Executive Officer of Concordia.

SOURCE Concordia Healthcare Corp.

Posted in: Business / Finance

Tags: Arthritis, Atrial Fibrillation, Cancer, Drugs, Epilepsy, Healthcare, Heart Failure, Irritable Bowel Syndrome, Lupus, Pharmaceuticals, Pheochromocytoma, Prostate Cancer, Rheumatoid Arthritis

Comments (0)

Download PDF Copy

Suggested Reading

Study reveals AI's potential and pitfalls in medical diagnosis

Study reveals AI's potential and pitfalls in medical diagnosis

AI tools improve maternity care outcomes for women

AI tools improve maternity care outcomes for women

Remote interpreting raises concerns about communication quality in healthcare

Remote interpreting raises concerns about communication quality in healthcare

Non-Hispanic Black children and low-income youth disadvantaged in concussion care

Non-Hispanic Black children and low-income youth disadvantaged in concussion care

Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare

Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare

FDA strengthens AI regulation to ensure patient safety and innovation in healthcare

FDA strengthens AI regulation to ensure patient safety and innovation in healthcare

Review highlights advances in flexible optoelectronics for cardiac healthcare

Review highlights advances in flexible optoelectronics for cardiac healthcare

Exploring AI's role in transforming healthcare diagnosis and treatment

Exploring AI's role in transforming healthcare diagnosis and treatment

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Brief behavioral intervention reduces intrusive memories of trauma in healthcare workers post-COVID-19